Progress in understanding of relationship between underlying liver diseases and liver metastasis of colorectal cancer

doi:10.3877/cma.j.issn.1674-0785.2023.07.010

Abstract

Abstract:

Liver metastasis is one of the main reasons for treatment failure in patients with colorectal cancer, and factors affecting liver metastasis have become a research focus of colorectal cancer. The underlying liver diseases not only affect the function of the liver, but also have a close correlation with liver metastasis of colorectal cancer. This paper reviews the progress in the understanding of the relationship between underlying liver diseases, such as cirrhosis, viral hepatitis B, and non-alcoholic fatty liver, and liver metastasis of colorectal cancer and explores the possible mechanisms involved, laying a theoretical foundation for future research.

Key words: Cirrhosis, Viral hepatitis B, Nonalcoholic fatty liver, Colorectal cancer, Hepatic metastases

Fanbiao Kong, Jianrong Yang. Progress in understanding of relationship between underlying liver diseases and liver metastasis of colorectal cancer[J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(07): 818-822.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlcyszz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0785.2023.07.010

https://zhlcyszz.cma-cmc.com.cn/EN/Y2023/V17/I07/818

References 52

1	Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2021, 71(3): 209-249.
2	Zheng R, Zhang S, Zeng H, et al. Cancer incidence and mortality in China, 2016 [J]. J Natl Cancer Cent, 2022, 2(1): 1-9.
3	中国医师协会外科医师分会, 中华医学会外科分会胃肠外科学组, 中华医学会外科分会结直肠外科学组, 等. 中国结直肠癌肝转移诊断和综合治疗指南(V2020) [J]. 中华胃肠外科杂志, 2021, 24(1): 1-13.
4	国家卫生健康委员会. 结直肠癌诊疗规范(2018年版) [J/OL]. 中华消化病与影像杂志(电子版), 2019, 9(3): 118-144.
5	中华医学会肝病学分会. 肝硬化诊治指南[J].中华肝脏病杂志, 2019, 27(11): 846-865.
6	Gunarathne LS, Rajapaksha H, Shackel N, et al. Cirrhotic portal hypertension: From pathophysiology to novel therapeutics [J]. World J Gastroenterol, 2020, 26(40): 6111-6140.
7	Lunova M, Frankova S, Gottfriedova H, et al. Portal hypertension is the main driver of liver stiffness in advanced liver cirrhosis [J]. Physiol Res, 2021, 70(4): 563-577.
8	Ginès P, Krag A, Abraldes JG, et al. Liver cirrhosis [J]. Lancet, 2021, 398(10308): 1359-1376.
9	Kaps L, Schuppan D. Targeting cancer associated fibroblasts in liver fibrosis and liver cancer using nanocarriers [J]. Cells, 2020, 9(9): 2027.
10	中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会. 肝纤维化诊断及治疗共识(2019年) [J]. 中华肝脏病杂志, 2019, 27(9): 657-667.
11	Barry AE, Baldeosingh R, Lamm R, et al. Hepatic stellate cells and hepatocarcinogenesis [J]. Front Cell Dev Biol, 2020, 8: 709.
12	Wu Y, Cao Y, Xu K, et al. Dynamically remodeled hepatic extracellular matrix predicts prognosis of early-stage cirrhosis [J]. Cell Death Dis, 2021, 12(2): 163.
13	Cao J, Luo SM, Liang L, et al. Effects of parenteral nutrition without and with growth hormone on growth hormone/insulin-like growth factor-1 axis after hepatectomy in hepatocellular carcinoma with liver cirrhosis [J]. JPEN J Parenter Enteral Nutr, 2007, 31(6): 496-501.
14	Anzo M, Cobb LJ, Hwang DL, et al. Targeted deletion of hepatic Igf1 in TRAMP mice leads to dramatic alterations in the circulating insulin-like growth factor axis but does not reduce tumor progression [J]. Cancer Res, 2008, 68(9): 3342-3349.
15	Holdaway IM, Mason BH, Lethaby AE, et al. Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 following chemotherapy for advanced breast cancer [J]. ANZ J Surg, 2003, 73(11): 905-908.
16	Kasprzak A. Insulin-Like growth factor 1 (IGF-1) signaling in glucose metabolism in colorectal cancer [J]. Int J Mol Sci, 2021, 22(12): 6434.
17	Sanchez-Lopez E, Flashner-Abramson E, Shalapour S, et al. Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling [J]. Oncogene, 2016, 35(20): 2634-44.
18	Lee HK, Lee JH, Kim M, et al. Insulin-like growth factor-1 induces migration and expression of laminin-5 in cultured human corneal epithelial cell [J]. Invest Ophthalmol Vis Sci, 2006, 47(3): 873-882.
19	Livingstone C. IGF2 and cancer [J]. Endocr Relat Cancer, 2013, 20(6): R321-39.
20	Song BC, Chung YH, Kim JA, et al. Association between insulin-like growth factor-2 and metastases after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma: a prospective study [J]. Cancer, 2001, 91(12): 2386-2393.
21	Feng X, Aleem E, Lin Y, et al. Multiple antitumor effects of picropodophyllin in colon carcinoma cell lines: clinical implications [J]. Int J Oncol, 2012, 40(4): 1251-1258.
22	Kasprzak A, Adamek A. Insulin-like growth factor 2 (IGF2) signaling in colorectal cancer-from basic research to potential clinical applications [J]. Int J Mol Sci, 2019, 20(19): 4915.
23	Lv J, Liu C, Chen FK, et al. M2-like tumour-associated macrophage-secreted IGF promotes thyroid cancer stemness and metastasis by activating the PI3K/AKT/mTOR pathway [J]. Mol Med Rep, 2021, 24(2): 604.
24	Chen Y, Tian Z. HBV-Induced immune imbalance in the development of HCC [J]. Front Immunol, 2019, 10: 2048.
25	Kuppen PJ, Gorter A, Hagenaars M, et al. Role of NK cells in adoptive immunotherapy of metastatic colorectal cancer in a syngeneic rat model [J]. Immunol Rev, 2001, 184: 236-43.
26	Shimasaki N, Jain A, Campana D. NK cells for cancer immunotherapy [J]. Nat Rev Drug Discov, 2020, 19(3): 200-218.
27	Jiang K, Chen H, Fang Y, et al. Exosomal ANGPTL1 attenuates colorectal cancer liver metastasis by regulating Kupffer cell secretion pattern and impeding MMP9 induced vascular leakiness [J]. J Exp Clin Cancer Res, 2021, 40(1): 21.
28	Chen LM, Fan XG, Ma J, et al. Molecular mechanisms of HBeAg in persistent HBV infection [J]. Hepatol Int, 2017, 11(1): 79-86.
29	Zhang GL, Zhao QY, Xie C, et al. Elevated serum IgG levels positively correlated with IL-27 may indicate poor outcome in patients with HBV-Related acute-on-chronic liver failure [J]. J Immunol Res, 2019, 2019: 1538439.
30	Suga M, Arima K, Yachi A. Detection of IgM, IgA, and IgG antibodies to preS2 antigen in hepatitis B virus infection [J]. Digestion, 1991, 50(3-4): 153-161.
31	Li Q, Lu Q, Zhu MQ, et al. Lower level of complement component C3 and C3a in the plasma means poor outcome in the patients with hepatitis B virus related acute-on-chronic liver failure [J]. BMC Gastroenterol, 2020, 20(1): 106.
32	Faille D, Labreuche J, Meseguer E, et al. Endothelial markers are associated with thrombolysis resistance in acute stroke patients [J]. Eur J Neurol, 2014, 21(4): 643-647.
33	Tunçbilek S. Relationship between cytokine gene polymorphisms and chronic hepatitis B virus infection [J]. World J Gastroenterol, 2014, 20(20): 6226-6235.
34	Navi BB, Sherman CP, Genova R, et al. Mechanisms of Ischemic Stroke in Patients with Cancer: A Prospective Study [J]. Ann Neurol, 2021, 90(1): 159-169.
35	Sutton CD, O'Byrne K, Goddard JC, et al. Expression of thrombospondin-1 in resected colorectal liver metastases predicts poor prognosis [J]. Clin Cancer Res, 2005, 11(18): 6567-6573.
36	Teraoku H, Morine Y, Ikemoto T, et al. Role of thrombospondin-1 expression in colorectal liver metastasis and its molecular mechanism [J]. J Hepatobiliary Pancreat Sci, 2016, 23(9): 565-73.
37	Tokunaga T, Nakamura M, Oshika Y, et al. Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer [J]. Br J Cancer, 1999, 79(2): 354-359.
38	Yoshida N, Kinugasa T, Miyoshi H, et al. A high RORγT/CD3 ratio is a strong prognostic factor for postoperative survival in advanced colorectal cancer: analysis of helper T cell lymphocytes (Th1, Th2, Th17 and Regulatory T Cells) [J]. Ann Surg Oncol, 2016, 23(3): 919-9+27.
39	Lee JY, Seo EH, Oh CS, et al. Impact of circulating T helper 1 and 17 cells in the blood on regional lymph node invasion in colorectal cancer [J]. J Cancer, 2017, 8(7): 1249-1254.
40	von Lilienfeld-Toal M, Nattermann J, Feldmann G, et al. Activated gammadelta T cells express the natural cytotoxicity receptor natural killer p 44 and show cytotoxic activity against myeloma cells [J]. Clin Exp Immunol, 2006, 144(3): 528-33.
41	Xiao L, Cen D, Gan H, et al. Adoptive transfer of NKG2D CAR mRNA-engineered natural killer cells in colorectal cancer patients [J]. Mol Ther, 2019, 27(6): 1114-1125.
42	Cappuzzello E, Sommaggio R, Zanovello P, et al. Cytokines for the induction of antitumor effectors: The paradigm of Cytokine-Induced Killer (CIK) cells [J]. Cytokine Growth Factor Rev, 2017, 36: 99-105.
43	Ewen EM, Pahl JHW, Miller M, et al. KIR downregulation by IL-12/15/18 unleashes human NK cells from KIR/HLA-I inhibition and enhances killing of tumor cells [J]. Eur J Immunol, 2018, 48(2): 355-365.
44	Van der Meer JMR, Maas RJA, Guldevall K, et al. IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells [J]. Cancer Immunol Immunother, 2021, 70(5): 1305-1321.
45	Lusty E, Poznanski SM, Kwofie K, et al. IL-18/IL-15/IL-12 synergy induces elevated and prolonged IFN-γ production by ex vivo expanded NK cells which is not due to enhanced STAT4 activation [J]. Mol Immunol, 2017, 88: 138-147.
46	Kondo T, Okabayashi K, Hasegawa H, et al. The impact of hepatic fibrosis on the incidence of liver metastasis from colorectal cancer [J]. Br J Cancer, 2016, 115(1): 34-39.
47	Kanzaki M, Wada J, Nakatsuka A, et al. A case of type 2 diabetes and metastatic liver cancer exhibiting hypercholesterolemia with abnormal lipoprotein [J]. Intern Med, 2012, 51(6): 619-623.
48	Li Y, Su X, Rohatgi N, Zhang Y, et al. Hepatic lipids promote liver metastasis [J]. JCI Insight, 2020, 5(17): e136215.
49	Sun X, Essalmani R, Day R, et al. Proprotein convertase subtilisin/kexin type 9 deficiency reduces melanoma metastasis in liver [J]. Neoplasia, 2012, 14(12): 1122-1131.
50	Kusama T, Mukai M, Iwasaki T, et al. 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis [J]. Gastroenterology, 2002, 122(2): 308-317.
51	Ling Y, Yang L, Huang H, et al. Prognostic significance of statin use in colorectal cancer: A systematic review and meta-analysis [J]. Medicine (Baltimore), 2015, 94(25): e908.
52	Verna L, Ganda C, Stemerman MB. In vivo low-density lipoprotein exposure induces intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 correlated with activator protein-1 expression [J]. Arterioscler Thromb Vasc Biol, 2006, 26(6): 1344-1349.

[1]	Li Dai, Huiwei Deng, Huajing Guo, Furong Huang. Effect of continuous infusion of esketamine on postoperative sleep quality of patients undergoing laparoscopic colorectal cancer surgery [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(06): 408-412.
[2]	Jianmei Li, Jingjuan Deng, Qian Yang. Safety and follow-up evaluation of the combined treatment of hepatocellular carcinoma with hepatic cirrhosis and portal hypertension [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 41-44.
[3]	Fangyuan Wu, Xia Sun, Changfeng Lin, Zhensheng Zhang. Risk factors of HBV-associated cirrhosis complicated with acute upper gastrointestinal bleeding [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 45-47.
[4]	Xian Mo, Chuang Yang. Meta-analysis of risk factors for portal vein thrombosis in patients with cirrhosis [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 678-683.
[5]	Runzhi Chen, Dongmei Yang, Huiting Xu. PD-1 combined with surufatinib for the treatment of metastatic colon cancer with microsatellite stability and BRAF V600E mutation: A case report and review [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(05): 431-435.
[6]	Xiaona Wang, Wei Tan, Yue Li, Wenyan Jiang. Effects of predictive care on perioperative quality of life, mood, and complication in patients undergoing radical colorectal cancer surgery [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 525-529.
[7]	Wenlong Liang, Jie Cao, Qing Huang, Yong Lin, Hongli Huang, Ping Yang, Guanwei Li, He Hu. Efficacy and safety analysis of sintilimab combined with regofenib in the treatment of advanced colorectal cancer [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 409-413.
[8]	Wei Qin, Dan Wang, Yu Sun, Yuling Huo, Suping Zhu, Yanli Zheng, Rui Xue. Predictive value of serum laminin and typeⅣcollagen on liver cirrhosis with ophageal and gastric varices bleeding [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 447-451.
[9]	Wen Zhang, Mudan Song, Xueting Deng, Yun Zhang. Enhanced nutritional support assisted with octreotide in the treatment of esophageal and gastric variceal bleeding in patients with liver cirrhosis and risk factors for rebleeding [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 456-460.
[10]	Xiangyu Zhu, Jianmei Wang, Hui Zhang, Hongying Ye. Correlation analysis between left ventricular function parameters and liver cirrhosis using non-invasive left ventricular pressure-strain cycle [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 494-498.
[11]	Daijiang Liu, Junyan Jiang, Xiaoqiang Wan, Shaying Ma. Analysis of survival status and prognostic factors in patients with colorectal cancer with liver metastasis [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(05): 284-288.
[12]	Yongsheng Li, Jiahe Sun, Shuwei Guo, Yikang Lu, Hongzhou Liu. Short-term postoperative complications and their influencing factors in elderly patients with colorectal cancer [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(9): 962-967.
[13]	Feifei Wang, Guanglin Wang, Zesong Meng, Baokun Li, Longfei Cao, Juan Zhang, Chaoxi Zhou, Yuanyi Ding, Guiying Wang. Effect of IMPDH1 knockdown on biological behavior of human colon cancer SW480 and HT29 cells [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(08): 884-890.
[14]	Yadan Wang, Jing Wu, Boyang Huang, Miaomiao Wang, Chunmei Guo, Hui Su, Canghai Wang, Jing Wang, Pengpeng Ding, Hong Liu. Design and validation of white-light endoscopy model for predicting the nature of colorectal tumors [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(06): 655-661.
[15]	Yanzhao Wang, Pengfei Niu, Changmin Ding, Qingkun Gao, Zhaoya Gao, Ke An, Zhichao Zhai, Qingmin Zeng, Wensheng Zeng, Fuming Lei, Jin Gu. Primary repair of large abdominal wall defect caused by colorectal cancer: our experience with 13 cases [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(05): 557-561.

Please choose a citation manager

Content to export